Skip Navigation
Menu
Close

Kyungsun Kyle CHOI Foreign Attorney (Admitted in California)

T.+82-2-3703-1119 F.+82-2-737-9091/9092
Kyungsun Kyle CHOI Foreign Attorney
Kyungsun Kyle CHOI Foreign Attorney

Kyungsun Kyle CHOIForeign Attorney (Admitted in California)

T.+82-2-3703-1119 F.+82-2-737-9091/9092 E.gschoi@kimchang.com

Areas of Expertise

Bio

Kyungsun Kyle Choi is a foreign attorney in the firm's Health and Digital Healthcare Practice and is a member of the Mergers & Acquisitions and Corporate Investigations & White Collar Defense Practice. She also advises chemical and related industry clients including consumer goods on EH&S regulations that have been undergoing rapid changes with focused enforcement activities.

Ms. Choi represents a broad range of companies in the pharmaceutical/medical device/food/cosmetic sectors, specializing in pharmaceutical regulation, pricing and reimbursement, compliance, bribery and competition law issues relating to promotional and marketing practices in the industry, anti-counterfeiting strategies, M&A, and restructuring of business operations.

Ms. Choi's representative work in recent years includes advising pharmaceutical clients in negotiating price and reimbursement scope of innovative drugs as well as in renewal of contract under a Risk Sharing Program. She is also defending a major multinational pharmaceutical company in a drug price reduction and reimbursement suspension case due to alleged illegal marketing activities. Ms. Choi also regularly advises clients in negotiating settlement discussions on alleged adverse effect cases in clinical studies and product liabilities litigations.

Ms. Choi has also defended multiple clients in the pharmaceutical industry in a wide range of internal and government investigations for corporate fraud, corruption, fair trade law, and anti-bribery offenses.

Profile

Experience

Member, Code Deliberation Committee, Korean Research-based Pharmaceutical Industry Association (2010-2014) 

Kim & Chang (1996-Present)

Representative Activitiesshow

Awards

  • Acritas Star – Independently Rated Lawyers (Acritas, 2018-2019)

Publications/Activities
    • International Comparative Legal Guide to Drug & Medical Device Litigation 2020: Korea Chapter (Co-author, Global Legal Group, 2020) 
    • Global Legal Insights - Pricing & Reimbursement: Korea Chapter (Co-author, Global Legal Group, 2019-2020) 
    • Chambers Global Practice Guide - Pharmaceutical Advertising: Korea Chapter - Law & Practice (Co-author, Chambers & Partners, 2018-2019) 
    • Practical Law - Commercialisation of Healthcare in South Korea (Overview): Korea Chapter (Co-author, Thomson Reuters, 2018-2019) 
    • Getting the Deal Through - Government Relations: Korea Chapter (Co-author, Law Business Research, 2018) 
    • Practical Law - Commercialisation of Healthcare Global Guide 2015/16: Korea Chapter (Co-author, Thomson Reuters, 2015) 
    • Getting the Deal Through - Life Sciences: Korea Chapter (Co-author, Law Business Research, 2015) 
    • Getting the Deal Through - Pharmaceutical Antitrust: Korea Chapter (Co-author, Law Business Research, 2013-2018) 
    • Getting the Deal Through - Anti-Corruption Regulation: Korea Chapter (Co-author, Law Business Research, 2012-2015, 2019)

Education

    University of California, Hastings College of Law (J.D., 1994)

    Occidental College (A.B., 1986)

Qualifications

    Admitted to bar, California, 1995

Languages

English and Korean

INSIGHTS

Search Professionals

EXPERTISE RESET SEARCH

EXPERTISE

Close

EXPERTISE

레이어 닫기

Share

Close
  

Kyungsun Kyle CHOI
Foreign Attorney (Admitted in California)


T. +82-2-3703-1119      
F. +82-2-737-9091/9092
     


  




Kyungsun Kyle Choi is a foreign attorney in the firm's Health and Digital Healthcare Practice and is a member of the Mergers & Acquisitions and Corporate Investigations & White Collar Defense Practice. She also advises chemical and related industry clients including consumer goods on EH&S regulations that have been undergoing rapid changes with focused enforcement activities.

Ms. Choi represents a broad range of companies in the pharmaceutical/medical device/food/cosmetic sectors, specializing in pharmaceutical regulation, pricing and reimbursement, compliance, bribery and competition law issues relating to promotional and marketing practices in the industry, anti-counterfeiting strategies, M&A, and restructuring of business operations.

Ms. Choi's representative work in recent years includes advising pharmaceutical clients in negotiating price and reimbursement scope of innovative drugs as well as in renewal of contract under a Risk Sharing Program. She is also defending a major multinational pharmaceutical company in a drug price reduction and reimbursement suspension case due to alleged illegal marketing activities. Ms. Choi also regularly advises clients in negotiating settlement discussions on alleged adverse effect cases in clinical studies and product liabilities litigations.

Ms. Choi has also defended multiple clients in the pharmaceutical industry in a wide range of internal and government investigations for corporate fraud, corruption, fair trade law, and anti-bribery offenses.






    Member, Code Deliberation Committee, Korean Research-based Pharmaceutical Industry Association (2010-2014) 

    Kim & Chang (1996-Present)






Awards

  •   Acritas Star – Independently Rated Lawyers (Acritas, 2018-2019)

Publications/Activities

  •   International Comparative Legal Guide to Drug & Medical Device Litigation 2020: Korea Chapter (Co-author, Global Legal Group, 2020) 
  •   Global Legal Insights - Pricing & Reimbursement: Korea Chapter (Co-author, Global Legal Group, 2019-2020) 
  •   Chambers Global Practice Guide - Pharmaceutical Advertising: Korea Chapter - Law & Practice (Co-author, Chambers & Partners, 2018-2019) 
  •   Practical Law - Commercialisation of Healthcare in South Korea (Overview): Korea Chapter (Co-author, Thomson Reuters, 2018-2019) 
  •   Getting the Deal Through - Government Relations: Korea Chapter (Co-author, Law Business Research, 2018) 
  •   Practical Law - Commercialisation of Healthcare Global Guide 2015/16: Korea Chapter (Co-author, Thomson Reuters, 2015) 
  •   Getting the Deal Through - Life Sciences: Korea Chapter (Co-author, Law Business Research, 2015) 
  •   Getting the Deal Through - Pharmaceutical Antitrust: Korea Chapter (Co-author, Law Business Research, 2013-2018) 
  •   Getting the Deal Through - Anti-Corruption Regulation: Korea Chapter (Co-author, Law Business Research, 2012-2015, 2019)





Education

    University of California, Hastings College of Law (J.D., 1994)

    Occidental College (A.B., 1986)


Qualifications

    Admitted to bar, California, 1995


Languages
  •    English and Korean





Environment ,  Health ,  Anti-Corruption & Corporate Compliance ,  Technology, Media & Telecommunications ,  Product Liability & Consumer Claims ,  Mergers & Acquisitions ,  Europe ,  Foreign Direct Investment ,  Corporate Governance & Shareholder Disputes ,  Germany ,  COVID-19 Task Force